Strategy
MSTR
Meta Platforms
META
Oracle
ORCL
Amazon
AMZN
Salesforce
CRM
US Stock MarketDetailed Quotes
SER Serina Therapeutics
- 4.640
- -0.020-0.43%
Close Feb 26 16:00 ET
45.90MMarket Cap-77.33P/E (TTM)
4.864High4.640Low5.16KVolume4.770Open4.660Pre Close24.58KTurnover0.17%Turnover RatioLossP/E (Static)9.89MShares22.82552wk High-3.33P/B13.83MFloat Cap3.81052wk Low--Dividend TTM2.98MShs Float209.262Historical High--Div YieldTTM4.81%Amplitude3.810Historical Low4.760Avg Price1Lot Size
Serina Therapeutics News
Serina Therapeutics Appoints Dr. Jay Venkatesan to Its Board of Directors
Express News | Serina Therapeutics Appoints DR. Jay Venkatesan to Its Board of Directors
Stocks to Watch: Palantir Technologies, Synaptics, J&J Snack Foods, Serina Therapeutics
Serina Therapeutics's Shares Up Following $5M of Equity Financing
Serina Therapeutics Secures $5 Million for SER-252 Trials
Express News | Serina Therapeutics Inc - Funding to Advance Ser-252 Into Phase 1 Trial in H2 2025
Express News | Serina Therapeutics Receives Second $5 Million Tranche to Strengthen Cash Position Ahead of Phase 1 Clinical Trial in Advanced Parkinson's Disease Patients
Stocks to Watch: Serina Therapeutics, Powell Max, Silexion Therapeutics
Express News | Serina Therapeutics Inc - Transaction Eliminates $11.2 Million in Debt
Serina Therapeutics Announces Sale of UniverXome Subsidiary
Serina Therapeutics Appoints Karen J. Wilson to Board of Directors
Serina Therapeutics Names Karen Wilson to Its Bd of Directors
Express News | Serina Therapeutics Welcomes Karen J. Wilson to Its Board of Directors
Serina Therapeutics to Present at Tribe Public's Webinar Event "Enabling Continuous Drug Delivery for Parkinson's Disease & Beyond" on Wednesday, December 18, 2024
Serina Therapeutics to Present at the 3rd Annual LNP Immunogenicity & Toxicity Summit
Serina Therapeutics Shares Rise After $10 Million in Financing
Why Credo Technology Group Shares Are Trading Higher By 40%; Here Are 20 Stocks Moving Premarket
Serina Therapeutics Secures $10 Million Financing to Continue Advancing Lead IND Candidate Into Phase 1 Clinical Trial in Advanced Parkinson's Disease Patients
Express News | Serina Therapeutics Secures $10 Million Financing to Continue Advancing Lead Ind Candidate Into Phase 1 Clinical Trial in Advanced Parkinson's Disease Patients
Express News | Serina Therapeutics Inc: Today Announced $10 Mln Equity Financing With Strategic Shareholder Juvventures (UK) Limited
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.